Cargando…
Feasibility of autologous plasma gel for tonsil-derived stem cell therapeutics in hypoparathyroidism
Hypoparathyroidism is a deficiency of the parathyroid hormone (PTH) in the body. We previously reported the possibility of treating it using tonsil-derived mesenchymal stem cells (TMSCs) differentiated into PTH-releasing cells. The purpose of this study was to evaluate the feasibility of using autol...
Autores principales: | Jung, Soo Yeon, Kim, Ha Yeong, Oh, Hyun Ju, Choi, Euno, Cho, Min Sun, Kim, Han Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085304/ https://www.ncbi.nlm.nih.gov/pubmed/30093637 http://dx.doi.org/10.1038/s41598-018-30454-1 |
Ejemplares similares
-
Standardization of A Physiologic Hypoparathyroidism Animal Model
por: Jung, Soo Yeon, et al.
Publicado: (2016) -
Density-Dependent Differentiation of Tonsil-Derived Mesenchymal Stem Cells into Parathyroid-Hormone-Releasing Cells
por: Kim, Ji Yeon, et al.
Publicado: (2022) -
Tonsil-derived stem cells as a new source of adult stem cells
por: Cho, Kyung-Ah, et al.
Publicado: (2019) -
Autologous Platelet-Poor Plasma Gel for Injection Laryngoplasty
por: Woo, Seung Hoon, et al.
Publicado: (2013) -
Application of Tonsil‐Derived Mesenchymal Stem Cells in Tissue Regeneration: Concise Review
por: Oh, Se‐Young, et al.
Publicado: (2019)